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Introduction:  Patients with ST elevation myocardial infarction (STEMI) with diabetes mellitus (DM) have an increased mortality and morbidity. 
Information is limited about clinical outcome in STEMI patients with insulin dependent DM (IDDM) compared to patients with non insulin dependent 
DM (NIDDM) treated with primary percutaneous coronary intervention (pPCI).
Methods: Between 1997 and 2007, we admitted 4506 patients with STEMI treated with pPCI at the Academic Medical Center in Amsterdam. 
Patients with IDDM and NIDDM were identified from our Cathlab database. We analyzed 5-year mortality. Cox regression was used for multivariate 
analysis.
Results: A total of 465 patients (10%) had DM, of whom 165 had IDDM and 300 had NIDDM. Patients with IDDM were older and had a higher 
prevalence of hypercholesterolemia, there were no other differences in baseline characteristics. Kaplan Meier estimates for 5-year mortality in IDDM 
patients were 36% vs. 20% in NIDDM patients. After multivariate analysis, IDDM was an independent predictor of mortality with a hazard ratio (HR) 
of 2.1 (95% confidence interval 1.4-3.2, p<0.01). Other independent predictors of mortality were cardiogenic shock (HR 4.2, p<0.01) age (HR 1.037 
per year increment, p<0.01). Postprocedural TIMI 3 flow was associated with improved survival (HR 0.5, p<0.01).
Conclusion: Among diabetic STEMI patients treated with primary PCI, patients with IDDM have a worse 5-year survival when compared to patients 
with NIDDM (adjusted HR 2.0)
